Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
25.5%
% of CANC's 47 holdings also in SBIO
13.5%
% of SBIO's 89 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
AGIOS PHARMACEUTICALS INC | 2.1% | 1.6% | 1.6% |
|
ARCELLX, INC. | 1.3% | 3.2% | 1.3% |
 |
MERUS N.V. | 1.3% | 2.2% | 1.3% |
|
CELLDEX THERAPEUTICS INC | 1.5% | 1.2% | 1.2% |
|
INTELLIA THERAPEUTICS, INC. | 1.5% | 0.9% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to SBIO
 |
ASTRAZENECA PLC | 5.6% |
|
GILEAD SCIENCES INC | 5.3% |
|
REGENERON PHARMACEUTICALS | 5.0% |
 |
ARGENX SE ADR | 4.6% |
|
BLUEPRINT MEDICINES CORP. | 4.6% |
|
INCYTE CORP | 4.3% |
|
ILLUMINA INC | 4.2% |
|
REVOLUTION MEDICINES, INC. | 4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
EXELIXIS INC | 3.6% |
CANC Underweight Relative to SBIO
|
CORCEPT THERAPEUTICS INC | -4.2% |
 |
ALKERMES PLC | -3.6% |
|
KRYSTAL BIOTECH, INC. | -3.4% |
|
CRINETICS PHARMACEUTICALS INC | -3.1% |
|
AVIDITY BIOSCIENCES INC | -2.7% |
|
PTC THERAPEUTICS INC | -2.5% |
|
DENALI THERAPEUTICS INC. | -2.3% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% |
|
ACADIA PHARMACEUTICALS INC | -2.1% |
|
VERICEL CORPORATION | -2.0% |